DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

NCT06539182 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Interventions

DRUG: DZD8586
DRUG: DZD8586
DRUG: DZD8586

Sponsor

Dizal Pharmaceuticals